Recurrence: all 3,523 studies
Page 24 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin's Lymphoma Receiving Brentuximab VedotinStatus unknownNCT03440788
- Multi Parametric Test Predicting the Risk of Colorectal Neoplasia RecurrenceStatus unknownNCT03434925Not applicable
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- Assessment of BladderLight SurvEILlanceStatus unknownNCT03427034Phase 2/3
- Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant GliomasStatus unknownNCT03423992Phase 1
- Atezolizumab, Rituximab, Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory DLBCL Not Suitable for High-dose TherapyTerminatedNCT03422523Phase 2
- Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic EvolutionCompletedNCT03421015
- Denosumab: A Potential Treatment Option for Aneurysmal Bone CystsCompletedNCT03415477Phase 1/2
- Clinical Study of ET190L1 ARTEMIS™ in Relapsed, Refractory B Cell LymphomaCompletedNCT03415399Phase 1
- Feasibility of Re-TREPP in Patients With a Recurrent Inguinal Hernia After Previous TREPP RepairCompletedNCT03411226
- Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)TerminatedNCT03410407
- PET Imaging of the Immune System Using Analog ProbesCompletedNCT03409419
- Vinorelbine for Recurrent ACLCCompletedNCT03397953Phase 2
- Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid AddictionStatus unknownNCT03394911Phase 3
- CART-19 Cells for R/R B-cell LymphomaStatus unknownNCT03391726Phase 2/3
- A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)Active, not recruitingNCT03385226Phase 2
- Gut Mucosal Microbiota is Associated With Colorectal Cancer RelapseStatus unknownNCT03385213
- Maintenance Therapy of 308-nm Excimer Laser Therapy in Patients With VitiligoStatus unknownNCT03384459Not applicable
- CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AMLStatus unknownNCT03384225Phase 3
- CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AMLStatus unknownNCT03384212Phase 3
- Chemoradiation vs Immunotherapy and Radiation for Head and Neck CancerActive, not recruitingNCT03383094Phase 2
- Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's LymphomaTerminatedNCT03379493Phase 1
- Apatinib for Relapsed and Refractory Diffuse Large B Cell LymphomaCompletedNCT03376958Phase 4
- A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)TerminatedNCT03374085Phase 1/2
- Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic LymphomaWithdrawnNCT03370185Phase 2
- Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC AdenocarcinomaWithdrawnNCT03361319Phase 1/2
- Pralatrexate for Relapsed or Refractory Peripheral T-cell LymphomaCompletedNCT03356678
- BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell CarcinomasActive, not recruitingNCT03355976Phase 2
- Retrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Life ConditionsCompletedNCT03353545
- Mechanisms of Mindfulness-Based Cognitive Therapy in the Treatment of Recurrent Major Depressive DisorderCompletedNCT03353493Not applicable
- Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLsStatus unknownNCT03346642Phase 1/2
- Research on the Efficacy of the "T.O.P. Computer Training" Procedure in the Treatment of Alcohol DependenceCompletedNCT03338361Not applicable
- PRecISion Medicine for Children With CancerActive, not recruitingNCT03336931
- Clinical Study on Triple Negative Breast Cancer With Chinese MedicineStatus unknownNCT03332368
- Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast CancerCompletedNCT03326102Phase 2
- A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With Relapsed/Refractory FLT3-Mutated Acute Myeloid LeukemiaWithdrawnNCT03324243Phase 2
- Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Status unknownNCT03321890Phase 2
- MB-CART19.1 in Patients With R/R ALLStatus unknownNCT03321123Phase 2
- Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line TherapyActive, not recruitingNCT03315364Phase 2/3
- Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]CompletedNCT03312166Not applicable
- Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin LymphomaCompletedNCT03302728Phase 1
- INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTIWithdrawnNCT03299387Phase 4
- Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian CancerStatus unknownNCT03298074Phase 2
- Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After AllotransplantStatus unknownNCT03297528Phase 2
- Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic ResponseStatus unknownNCT03296397Phase 3
- Comparing Efficacy of Chest Tube Drainage and Needle Aspiration in Pneumothorax TreatmentStatus unknownNCT03293199Not applicable
- Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in KoreaCompletedNCT03288974
- Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory RetinoblastomaCompletedNCT03284268Not applicable
- 7 Days Versus 14 Days of Antibiotics for Neonatal SepsisCompletedNCT03280147Phase 3
- Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing SarcomaCompletedNCT03275818Phase 2
- CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic LeukemiaStatus unknownNCT03275493Phase 1/2
- Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple MyelomaTerminatedNCT03266692Phase 1
- Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid UseStatus unknownNCT03266445Phase 4
- 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILICompletedNCT03266146Phase 1/2
- Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of SarcoidosisCompletedNCT03265405Phase 4
- A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma SubjectsStatus unknownNCT03265106Phase 1/2
- Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesCompletedNCT03263637Phase 1
- Lime Powder Regimen (LPR) for Prevention of Renal Stone RecurrenceCompletedNCT03258190Phase 2
- MRS and Medication Response: A Pilot StudyTerminatedNCT03254342
- Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-CaCompletedNCT03250520Early Phase 1
- Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AMLCompletedNCT03250338Phase 3
- Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted StatesStatus unknownNCT03248180
- Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHLStatus unknownNCT03245905Phase 2
- Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK CellsStatus unknownNCT03242603Phase 1/2
- A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesCompletedNCT03236857Phase 1
- Comparison Between Two Different High Power Ablative Lasers in the Treatment of Oral LeukoplakiaCompletedNCT03233165Not applicable
- A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma.Active, not recruitingNCT03233152Phase 1/2
- Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)Status unknownNCT03230201Not applicable
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's LymphomasTerminatedNCT03220347Phase 1
- Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.TerminatedNCT03218683Phase 1
- Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal IntCompletedNCT03213964Phase 1
- Smoking Cessation After Acute Coronary SyndromeCompletedNCT03209622Not applicable
- Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell LymphomaStatus unknownNCT03208556Phase 1
- iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)WithdrawnNCT03207334Phase 2
- Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT03207191Phase 1
- Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell LymphomaStatus unknownNCT03207178Phase 1/2
- A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar PatientsCompletedNCT03207048Not applicable
- CAR-T for R/R B-NHLCompletedNCT03196830Phase 2
- The COLON Study: Colorectal Cancer CohortActive, not recruitingNCT03191110
- Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell LymphomaTerminatedNCT03189836Phase 1
- Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDSCompletedNCT03187288Phase 1
- Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory LymphomasActive, not recruitingNCT03179930Phase 2
- In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?CompletedNCT03174912Phase 4
- Phase Ib Study of Chiauranib in Patients With Ovarian CancerCompletedNCT03166891Phase 1/2
- A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)Active, not recruitingNCT03162536Phase 1/2
- Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial FibrillationWithdrawnNCT03162120Phase 2/3
- Chronic Convection Enhanced Delivery of TopotecanCompletedNCT03154996Phase 1
- Axicabtagene Ciloleucel Expanded Access StudyApproved for marketingNCT03153462
- Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB RecurrenceCompletedNCT03152903Phase 2/3
- Study of Mindfulness Practice Efficacy in Alcoholic Relapse PreventionStatus unknownNCT03150550Not applicable
- Study of AMV564 in Patients With AMLCompletedNCT03144245Phase 1
- Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory MyelomaStatus unknownNCT03143036Phase 2
- Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBCStatus unknownNCT03138824Not applicable
- iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AMLWithdrawnNCT03138395
- Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and NeckCompletedNCT03132038Phase 2
- Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid LeukemiaTerminatedNCT03126864Phase 1
- Re-Irradiation of Progressive or Recurrent DIPGCompletedNCT03126266Not applicable
- A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)Status unknownNCT03121768
- Interferon-α Prevents Leukemia Relapse of AML Patients After TransplantationWithdrawnNCT03121079Not applicable
- Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCTStatus unknownNCT03114670Phase 1